CT Tumoral Heterogeneity As a Prognostic Marker in Primary Esophageal Cancer Following Neoadjuvant Chemotherapy
Overview
Affiliations
MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer.
Owczarczyk K, Prezzi D, Cascino M, Kozarski R, Gaya A, Siddique M Radiother Oncol. 2019; 134:119-126.
PMID: 31005205 PMC: 7617040. DOI: 10.1016/j.radonc.2019.01.022.
New PET/CT Features for the Evaluation of Tumor Response.
Lu W J Nucl Med Radiat Ther. 2018; 4(3).
PMID: 30310728 PMC: 6176869. DOI: 10.4172/2155-9619.1000e110.
Tan X, Ma Z, Yan L, Ye W, Liu Z, Liang C Eur Radiol. 2018; 29(1):392-400.
PMID: 29922924 DOI: 10.1007/s00330-018-5581-1.
Lu W, Chen W Transl Cancer Res. 2016; 5(4):364-370.
PMID: 27904837 PMC: 5124903. DOI: 10.21037/tcr.2016.07.12.
Computerized PET/CT image analysis in the evaluation of tumour response to therapy.
Lu W, Wang J, Zhang H Br J Radiol. 2015; 88(1048):20140625.
PMID: 25723599 PMC: 4651254. DOI: 10.1259/bjr.20140625.